MAPT and Alzheimer disease: Furthermore, in addition to imaging, biochemical markers derived from CSF including Aβ42, phosphorylated tau (P-tau181), and neurofilament light chain (NfL) suggest first-tier indicators of AD pathophysiology and neuronal degeneration that are associated with the disorder of GLU signaling [168].